----
Current ValuationThe current P/E ratio is 11.38, within the reasonable range, cheaper than 48.85% of the time in the past 1 years, and the industry ranks 1/84, the industry Median 11.38.
11.38xP/E
¥117.34Stock price
¥10.31Earnings per share
11.38xP/E
Stock price¥117.34Earnings per share¥10.31
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 11.29x
- Typical range
- -57.68x–55.80x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.38x
03978117156
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.38x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
688331SHRemeGen | 11.38x | 486.37% | ¥66.24B |
688336SHSunshine Guojian Pharmaceutical | 12.05x | 78.00% | ¥37.13B |
688278SHAMOYTOP | 19.99x | 19.44% | ¥21.59B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
